|
FKBP15 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.54569999986232E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.724100E-03 |
| Normal-vs-Stage2 |
1.059180E-03 |
| Normal-vs-Stage3 |
8.838000E-02 |
| Normal-vs-Stage4 |
3.593800E-01 |
| Stage1-vs-Stage2 |
1.998080E-02 |
| Stage1-vs-Stage3 |
7.493800E-01 |
| Stage1-vs-Stage4 |
8.095200E-01 |
| Stage2-vs-Stage3 |
1.753570E-02 |
| Stage2-vs-Stage4 |
9.615800E-02 |
| Stage3-vs-Stage4 |
9.644200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.39699999999843E-05 |
| Normal-vs-AfricanAmerican |
1.536940E-03 |
| Normal-vs-Asian |
3.434400E-01 |
| Caucasian-vs-AfricanAmerican |
5.364000E-01 |
| Caucasian-vs-Asian |
9.800000E-01 |
| AfricanAmerican-vs-Asian |
8.227400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.48619999995603E-06 |
| Normal-vs-Female |
1.515740E-03 |
| Male-vs-Female |
8.411200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.217800E-02 |
| Normal-vs-Extreme_Weight |
2.426500E-04 |
| Normal-vs-Obese |
3.643700E-03 |
| Normal-vs-Extreme_Obese |
7.302200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.911000E-01 |
| Normal_Weight-vs-Obese |
5.684600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.704000E-01 |
| Extreme_Weight-vs-Obese |
9.908200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.828240E-01 |
| Obese-vs-Extreme_Obese |
2.751000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.455700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.63719999948897E-07 |
| Normal-vs-Age(61-80Yrs) |
1.141040E-03 |
| Normal-vs-Age(81-100Yrs) |
1.434570E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.775200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.793600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.479000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.749700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.751800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.292000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.909799995925E-08 |
| Normal-VS-Type2 PRCC |
3.728400E-02 |
| Normal-VS-KIRP CIMP |
7.207400E-01 |
| Normal-VS-Unclassified PRCC |
4.778400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.480400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.430300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.035200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.080400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.504590E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.515800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.744700E-03 |
| Normal-vs-N1 |
3.584300E-02 |
| Normal-vs-N2 |
6.893400E-01 |
| N0-vs-N1 |
8.143400E-01 |
| N0-vs-N2 |
2.486000E-01 |
| N1-vs-N2 |
2.538600E-01 |
|
|
